Skip to main content

Table 1 Demographic characteristics of 2303 patients

From: The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-oncological research group registration

  Overall University hospital Affiliated hospitals  
  n = 2303 (%) n = 420 (%) n = 1883 (%) P value
Age (years)     
younger than 60 154 (6.7) 52 (12.4) 102 (5.4)  
60-69 684 (29.7) 130 (31.0) 554 (29.4)  
70-79 1117 (48.5) 199 (47.3) 918 (48.8)  
80 or older 348 (15.1) 39 (9.3) 309 (16.4) < 0.001
PSA at diagnosis     
10.0 or less 963 (41.8) 225 (53.5) 738 (39.2)  
10.1-20 554 (24.1) 98 (23.3) 456 (24.2)  
greater than 20 786 (34.1) 97 (23.1) 689 (36.6) < 0.001
Gleason score     
2-6 906 (39.3) 146 (34.8) 760 (40.3)  
7 722 (31.4) 175 (41.6) 547 (29.0)  
8-10 675 (29.3) 99 (23.6) 576 (30.6) < 0.001
Clinical T stage     
T1 766 (33.3) 183 (43.6) 583 (31.0)  
T2 933 (40.5) 134 (31.9) 799 (42.4)  
T3 489 (21.2) 95 (22.6) 394 (20.9)  
T4 115 (5.0) 8 (1.9) 107 (5.7) < 0.001
  1. Chi-square test.